APA (7th ed.) Citation

H, C., M, A., M, H., KE, L., R, X., G, M., . . . MR, P. (2013). Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. The Journal of clinical investigation, 123(11), 4681. https://doi.org/10.1172/JCI65764

Chicago Style (17th ed.) Citation

H, Court, et al. "Isoprenylcysteine Carboxylmethyltransferase Deficiency Exacerbates KRAS-driven Pancreatic Neoplasia via Notch Suppression." The Journal of Clinical Investigation 123, no. 11 (2013): 4681. https://doi.org/10.1172/JCI65764.

MLA (9th ed.) Citation

H, Court, et al. "Isoprenylcysteine Carboxylmethyltransferase Deficiency Exacerbates KRAS-driven Pancreatic Neoplasia via Notch Suppression." The Journal of Clinical Investigation, vol. 123, no. 11, 2013, p. 4681, https://doi.org/10.1172/JCI65764.